Stay updated on FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial
Sign up to get notified when there's something new on the FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial page.

Latest updates to the FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedLocations section updated with new sites: Hong Kong Island, Kowloon, New Territories, Bangkok Noi, Changwat Songkhla, and Chiang Mai. The page reorganized location sections under a single Locations heading, removing some previously listed location subsections.SummaryDifference0.8%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2. The Study Details page content and layout appear unchanged.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1; there are no changes to study data, eligibility criteria, or page content beyond the version label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedRemoval of the site-wide government funding notice; the study details and page navigation remain unchanged.SummaryDifference0.4%

- Check63 days agoChange DetectedThe screenshots show the same study record with minor visual/UI differences and no changes to core trial information such as eligibility criteria, enrollment, or study status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check92 days agoChange DetectedThe page now includes a government-funding lapse notice and a new v3.2.0 update, replacing the old v3.1.0 tag.SummaryDifference5%

Stay in the know with updates to FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial page.